Skip to content

TACO Crossover TRIAL

A Cross-over Randomized Controlled Trial; Pulmonary Edema Detection After Fluid Loading With Blood Versus Saline in Patients After CABG

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03135457
Enrollment
16
Registered
2017-05-01
Start date
2017-08-16
Completion date
2020-04-01
Last updated
2020-08-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Transfusion Reaction, Transfusion-associated Circulatory Overload

Brief summary

This is an open-label, prospective crossover randomized controlled trial to investigate wether TACO is solely hydrostatic pressure overload or arises from a combination of hydrostatic pressure overload and capillary leakage, by investigating the difference in change in static pressure parameters (PCWP), dynamic volume parameters (PICCO) as indirect measurements of volume status and capillary leakage after autologous transfusion or saline infusion. The investigators will estimate effective circulating volume following autologous transfusion or saline infusion. Furthermore, the investigators will investigate the effect of fluid loading on the microcirculation.

Detailed description

Coronary arterial bypass grafting surgery patients with reduced left ventricular function will be allocated to either infusion of 300mL saline with a subsequent autologous RBC (cell saver) transfusion of 300 mL at a rate of 10mL/min, or the same in the reversed order. Prior to start of the intervention, 15 minutes following start of infusion and a the end of infusion, the investigators will measure right-ventricular pressure and wedge pressure (PCWP), as well as extravascular lung water index (EVLWI) and CO estimation through PICCO® and Pulmonary Artery Catheter. The investigators will identify fluid responsiveness by performing a passive leg raise test (PLR). The investigators aim to measure total vessel density (TVD), perfused vessel density (PVD), proportion of perfused vessels (PPV), microvascular flow index (MFI), and blood vessel diameters (Øbv) from the oral microcirculation by CytoCam microscope system. The investigators will estimate the effective circulating blood and plasma volume through dilutional infusion of indocyanine green prior to initial infusion, between and at the end of subsequent infusion.

Interventions

PROCEDUREAutologous RBC transfusion

Autologous RBC transfusion 300ml 10 ml/min

PROCEDURESaline transfusion

Saline transfusion 300ml 10ml/min

Sponsors

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Caregiver)

Masking description

Masking of investigator is not possible due to nature of intervention.

Intervention model description

Open-label, prospective cross-over randomized controlled trial.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \>18 years 2. Elective (non-redo) coronary arterial bypass grafting surgery 3. Reduced left ventricular ejection fraction (\<55%) 4. Transfusion of autologous blood (cell saver blood, 300ml, HCT60%, 30min) 5. Informed consent

Exclusion criteria

1. Patients with no indication for autologous RBC transfusion 2. Patients with pulmonary hypertension, congenital heart disease, mitral or tricuspid valve disease. 3. Contraindications for PAC placement; coagulopathy, bundle branch block, defibrillator or pacemaker (risk of displacement). External pacemaker placed during surgery is no exclusion criterium. 4. Patients for acute, non-elective surgery 5. Chronic kidney disease stage 4 or higher (eGFR \< 30) 6. Massive transfusion 7. Previous randomization in the current trial 8. Postoperative ongoing bleeding 9. Bypass duration \> 2 hours 10. Infusion of high dose corticosteroids 11. Hemodynamic instability with a mean arterial pressure (MAP) \< 60 mmHg, central venous pressure \> 20 mmHg or dependence on high dosages of inotropic drugs after admittance to the ICU 12. Severe arrhythmias 13. Development of severe pulmonary edema during infusion of autologous blood or saline. 14. Elevated liver enzymes 15. Iodine allergy

Design outcomes

Primary

MeasureTime frameDescription
Hydrostatic pressure overload1 hourHydrostatic pressure overload defined as delta pulmonary capillary wedge pressure

Secondary

MeasureTime frameDescription
Cardiac output1 hourVolume overload measured by cardiac output
Mean arterial pressure1 hourVolume overload measured by mean arterial pressure
Pulse pressure variation1 hourVolume overload measured by pulse pressure variation
Stroke volume variation1 hourVolume overload measured by stroke volume variation
Extra vascular lung water index1 hourVolume overload measured by extra vascular lung water index
Capillary leakage1 hourCapillary leakage defined as delta extra vascular lung water index
Colloid osmotic pressure1 hourColloid osmotic pressure measured by membrane colloid osmometer
Estimated circulating volume1 hourEstimated circulating blood volume measured by indocyanine green
Microcirculation1 hourTotal vessel density in the sublingual microcirculation measured by Cytocam
Fluid responsiveness1 hourFluid responsiveness defined by Passive Leg Raise test (increase in cardiac output \> 10%)
TACO6 hoursTransfusion associated circulatory overload criteria 6 hours after infusion of autologous blood transfusion
Systemic vascular resistance1 hourVolume overload measured by systemic vascular resistance

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026